List of Excipients in API atorvastatin calcium, film coated
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing atorvastatin calcium, film coated
Detailed excipient profiles for atorvastatin calcium, film coated
Excipient focus: CALCIUM CARBONATE
atorvastatin calcium, film coated drug variants containing CALCIUM CARBONATE
atorvastatin calcium, film coated drug variants not containing CALCIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
atorvastatin calcium, film coated drug variants containing CELLULOSE, MICROCRYSTALLINE
atorvastatin calcium, film coated drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
atorvastatin calcium, film coated drug variants containing CROSCARMELLOSE SODIUM
atorvastatin calcium, film coated drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
atorvastatin calcium, film coated drug variants containing HYDROXYPROPYL CELLULOSE
atorvastatin calcium, film coated drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
atorvastatin calcium, film coated drug variants containing HYPROMELLOSE
atorvastatin calcium, film coated drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
atorvastatin calcium, film coated drug variants containing HYPROMELLOSES
atorvastatin calcium, film coated drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
atorvastatin calcium, film coated drug variants containing LACTOSE MONOHYDRATE
atorvastatin calcium, film coated drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
atorvastatin calcium, film coated drug variants containing MAGNESIUM STEARATE
atorvastatin calcium, film coated drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
atorvastatin calcium, film coated drug variants containing POLYETHYLENE GLYCOL
atorvastatin calcium, film coated drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
atorvastatin calcium, film coated drug variants containing POLYSORBATE 80
atorvastatin calcium, film coated drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
atorvastatin calcium, film coated drug variants containing TALC
atorvastatin calcium, film coated drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
atorvastatin calcium, film coated drug variants containing TITANIUM DIOXIDE
atorvastatin calcium, film coated drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch